Physician profile
Walter Levy
NPI 1356333199
$2,013.52
in general payments reported to CMS, 2019-2025
22 companies · $99.99 in 2025
The $99.99 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $132 · 2021: $568 · 2022: $271 · 2023: $202 · 2024: $383 · 2025: $99.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.44 |
| Education | $185.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $511.50 | 2019-2025 | Myrbetriq |
| Sumitomo Pharma America, INC. | $238.07 | 2023-2024 | Gemtesa |
| Janssen Biotech, INC. | $205.24 | 2019-2024 | Erleada, Akeega |
| Urovant Sciences INC | $159.27 | 2021-2022 | |
| Coloplast Corp | $147.77 | 2020-2021 | |
| Antares Pharma, INC. | $81.46 | 2024 | Xyosted |
| Acerus Pharmaceuticals Corporation | $80.78 | 2021 | |
| Pfizer INC. | $79.17 | 2019-2024 | |
| Teleflex LLC | $75.71 | 2021 | |
| Abbvie INC. | $69.71 | 2021-2023 | |
| Allergan, INC. | $53.66 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $51.05 | 2019 | |
| Endo Pharmaceuticals INC. | $47.58 | 2020-2021 | |
| Progenics Pharmaceuticals, INC. | $38.11 | 2021 | |
| Halozyme INC | $32.97 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $31.02 | 2019 | |
| Accord Healthcare, INC. | $23.17 | 2022 | |
| Tolmar, INC. | $20.05 | 2024 | |
| Blue Earth Diagnostics | $19.50 | 2019 | |
| Urogen Pharma, INC. | $18.81 | 2022 | |
| Myriad Genetic Laboratories, INC. | $15.03 | 2023 | Prolaris |
| Rochester Medical Corporation | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.